Frank C. Schell
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 3
-
- Chemotherapy-related skin toxicity 3
- Co-authors
- George R. BlumenscheinAman U. BuzdarH. Y. YapGabriel N. HortobágyiEleanor D. MontagueWilliam J. SpanosHwee‐Yong YapGerald P. Bodey
- Journals
- Cancer (4 papers)Cancer Chemotherapy and Pharmacology (1 paper)Annals of Internal Medicine (1 paper)Journal of Surgical Oncology (1 paper)American Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Frank C. Schell
14 papers receiving 471 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 285
- Oncology 345
- Pathology and Forensic Medicine 150
- Dermatology 27
- Cardiology and Cardiovascular Medicine 57
Countries citing papers authored by Frank C. Schell
This map shows the geographic impact of Frank C. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank C. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank C. Schell more than expected).
Fields of papers citing papers by Frank C. Schell
This network shows the impact of papers produced by Frank C. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank C. Schell. The network helps show where Frank C. Schell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank C. Schell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 58 | |
| 2 | Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer. | 1984 | 7 |
| 3 | 1983 | 190 | |
| 4 | Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer. | 1983 | 7 |
| 5 | Bisantrene, an active new drug in the treatment of metastatic breast cancer. | 1983 | 26 |
| 6 | 1983 | 1 | |
| 7 | 1982 | 40 | |
| 8 | High-dose AMSA and bone marrow rescue in patients with solid tumors. | 1982 | 9 |
| 9 | 1982 | 2 | |
| 10 | 1982 | 7 | |
| 11 | Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer. | 1981 | 7 |
| 12 | 1981 | 79 | |
| 13 | 1981 | 8 | |
| 14 | 1981 | 61 |
About Frank C. Schell
Frank C. Schell is a scholar working on Oncology, Dermatology, Toxicology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 14 papers that have together received 502 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Research Studies (3 papers), Chemotherapy-related skin toxicity (3 papers), Cancer therapeutics and mechanisms (2 papers), Fungal Plant Pathogen Control (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Cancer Research (285 citations), Oncology (345 citations), Pathology and Forensic Medicine (150 citations), Dermatology (27 citations) and Cardiology and Cardiovascular Medicine (57 citations). Frank C. Schell has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include George R. Blumenschein, Aman U. Buzdar, H. Y. Yap, Gabriel N. Hortobágyi, Eleanor D. Montague, William J. Spanos, Hwee‐Yong Yap, Gerald P. Bodey, Manuel Valdivieso and Sewa S. Legha. Their work appears in journals such as Cancer, Cancer Chemotherapy and Pharmacology, Annals of Internal Medicine, Journal of Surgical Oncology and American Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.